X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13641) 13641
Book Review (1849) 1849
Publication (1362) 1362
Book Chapter (72) 72
Conference Proceeding (40) 40
Book / eBook (16) 16
Newsletter (9) 9
Dissertation (7) 7
Magazine Article (7) 7
Data Set (2) 2
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13268) 13268
humans (12981) 12981
female (8746) 8746
breast neoplasms - enzymology (7044) 7044
oncology (6168) 6168
animals (4046) 4046
breast cancer (3922) 3922
breast neoplasms - pathology (3768) 3768
cell line, tumor (3542) 3542
breast-cancer (3104) 3104
cancer (3039) 3039
middle aged (2976) 2976
expression (2562) 2562
aged (2299) 2299
mice (2269) 2269
male (2242) 2242
adult (2232) 2232
breast neoplasms - genetics (2227) 2227
breast neoplasms - drug therapy (2057) 2057
biochemistry & molecular biology (1944) 1944
cell biology (1713) 1713
immunohistochemistry (1618) 1618
metastasis (1604) 1604
apoptosis (1591) 1591
tumor cells, cultured (1527) 1527
neoplasms - enzymology (1461) 1461
prognosis (1443) 1443
breast neoplasms - metabolism (1440) 1440
tumors (1423) 1423
gene expression regulation, neoplastic (1284) 1284
phosphorylation (1186) 1186
research (1186) 1186
carcinoma (1183) 1183
signal transduction (1174) 1174
antineoplastic agents - pharmacology (1123) 1123
proteins (1117) 1117
cells (1096) 1096
gene expression (1091) 1091
neoplasm invasiveness (1074) 1074
activation (1006) 1006
aged, 80 and over (964) 964
growth (955) 955
analysis (929) 929
enzymes (911) 911
genetic aspects (893) 893
transfection (885) 885
article (874) 874
apoptosis - drug effects (844) 844
cell proliferation - drug effects (826) 826
mice, nude (806) 806
cell proliferation (795) 795
gene-expression (762) 762
pharmacology & pharmacy (762) 762
chemotherapy (760) 760
pathology (760) 760
research article (747) 747
health aspects (744) 744
enzyme inhibitors - pharmacology (738) 738
care and treatment (734) 734
risk factors (717) 717
neoplasm metastasis (712) 712
antineoplastic agents - therapeutic use (711) 711
blotting, western (706) 706
invasion (701) 701
breast (700) 700
physiological aspects (691) 691
signal transduction - drug effects (685) 685
kinases (684) 684
development and progression (681) 681
inhibition (671) 671
time factors (671) 671
medicine (664) 664
rna, messenger - genetics (635) 635
neoplasms - drug therapy (624) 624
enzyme activation (623) 623
mutation (623) 623
neoplasm staging (619) 619
up-regulation (608) 608
gene (607) 607
in-vitro (605) 605
lung neoplasms - enzymology (601) 601
gene expression regulation, enzymologic (600) 600
breast-cancer cells (599) 599
neoplasms - pathology (593) 593
multidisciplinary sciences (592) 592
reverse transcriptase polymerase chain reaction (585) 585
survival (576) 576
adenocarcinoma - enzymology (575) 575
proliferation (564) 564
dose-response relationship, drug (551) 551
angiogenesis (545) 545
prostate-cancer (543) 543
in-vivo (542) 542
estrogen (540) 540
biomarkers, tumor - metabolism (539) 539
rna, messenger - metabolism (539) 539
endocrinology & metabolism (538) 538
mcf-7 cells (530) 530
disease progression (528) 528
xenograft model antitumor assays (527) 527
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13258) 13258
Chinese (75) 75
German (75) 75
Russian (74) 74
Japanese (62) 62
French (56) 56
Italian (24) 24
Polish (22) 22
Spanish (16) 16
Hungarian (3) 3
Portuguese (3) 3
Hebrew (2) 2
Serbian (2) 2
Slovak (2) 2
Turkish (2) 2
Croatian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 15, pp. 2512 - 2519
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 9, pp. 852 - 861
Summary Background Olaparib (AZD2281) is a small-molecule, potent oral poly(ADP-ribose) polymerase (PARP) inhibitor. We aimed to assess the safety and... 
Hematology, Oncology and Palliative Medicine | POLY(ADP-RIBOSE) POLYMERASE | BRCA2 MUTATIONS | LIPOSOMAL DOXORUBICIN | RIBOSE POLYMERASE INHIBITORS | SOLID TUMORS | ONCOLOGY | GENETICS | GUIDELINES | SENSITIVITY | RESISTANCE | PARP INHIBITOR | Humans | Middle Aged | Ovarian Neoplasms - pathology | Carcinoma - mortality | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Enzyme Inhibitors - administration & dosage | Ovarian Neoplasms - genetics | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Time Factors | Aged, 80 and over | Cell Differentiation | Carcinoma - drug therapy | Enzyme Inhibitors - adverse effects | Phthalazines - administration & dosage | Administration, Oral | Piperazines - therapeutic use | Breast Neoplasms - drug therapy | Enzyme Inhibitors - therapeutic use | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors | Ovarian Neoplasms - enzymology | Canada | Breast Neoplasms - genetics | Carcinoma - genetics | Mutation | Receptor, ErbB-2 - analysis | Piperazines - administration & dosage | Receptors, Estrogen - analysis | Ovarian Neoplasms - mortality | Breast Neoplasms - enzymology | Antineoplastic Agents - adverse effects | Carcinoma - enzymology | Adult | Female | Ovarian Neoplasms - drug therapy | Carcinoma - secondary | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Treatment Outcome | BRCA1 Protein - genetics | Disease-Free Survival | Phthalazines - therapeutic use | Poly(ADP-ribose) Polymerases - metabolism | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Aged | BRCA2 Protein - genetics | Phthalazines - adverse effects | Care and treatment | Relapse | Gene mutations | Oncology, Experimental | Breast cancer | Research | Cancer | Diseases | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 08/2010, Volume 466, Issue 7308, pp. 869 - 873
Journal Article
Nature Cell Biology, ISSN 1465-7392, 2014, Volume 16, Issue 9, pp. 876 - 888
Journal Article
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7692, pp. 378 - 381
Journal Article
Cancer Research, ISSN 0008-5472, 05/2011, Volume 71, Issue 9, pp. 3364 - 3376
Journal Article
Nature, ISSN 0028-0836, 06/2015, Volume 522, Issue 7554, pp. 106 - 110
Journal Article
Oncogene, ISSN 0950-9232, 10/2013, Volume 32, Issue 44, pp. 5210 - 5219
Journal Article
Journal Article